These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 26079688

  • 1. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F, Emans ME, van der Putten K, Braam B, van Ittersum FJ, Kraaijenhagen RJ, de Borst MH, Vervloet M, Gaillard CA.
    PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
    [Abstract] [Full Text] [Related]

  • 2. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.
    Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
    [Abstract] [Full Text] [Related]

  • 3. Phosphate control in reducing FGF23 levels in hemodialysis patients.
    Rodelo-Haad C, Rodríguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, Agüera ML, Muñoz-Castañeda JR, Soriano S, Caravaca F, Alvarez-Lara MA, Felsenfeld A, Aljama P, Rodriguez M.
    PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
    [Abstract] [Full Text] [Related]

  • 4. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.
    Christodoulou M, Aspray TJ, Piec I, Fraser WD, Schoenmakers I, VDOP Trial group.
    Age Ageing; 2024 May 01; 53(5):. PubMed ID: 38770543
    [Abstract] [Full Text] [Related]

  • 5. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
    Hu MC, Reneau JA, Shi M, Takahashi M, Chen G, Mohammadi M, Moe OW.
    Am J Physiol Renal Physiol; 2024 Apr 01; 326(4):F584-F599. PubMed ID: 38299214
    [Abstract] [Full Text] [Related]

  • 6. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
    Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.
    Eur J Clin Invest; 2016 Mar 01; 46(3):234-41. PubMed ID: 26728476
    [Abstract] [Full Text] [Related]

  • 7. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
    Hanudel MR, Wesseling-Perry K, Gales B, Ramos G, Campbell V, Ethridge K, Scotti M, Elashoff DA, Alejos J, Reemtsen B, Salusky IB.
    Pediatr Nephrol; 2016 Apr 01; 31(4):661-9. PubMed ID: 26525200
    [Abstract] [Full Text] [Related]

  • 8. C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.
    Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL, de Borst MH, Gaillard CAJM.
    J Am Soc Nephrol; 2017 Dec 01; 28(12):3639-3646. PubMed ID: 28774998
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
    Bożentowicz-Wikarek M, Kocełak P, Owczarek A, Olszanecka-Glinianowicz M, Mossakowska M, Skalska A, Więcek A, Chudek J.
    Clin Biochem; 2015 Apr 01; 48(6):431-6. PubMed ID: 25583093
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biological variability of plasma intact and C-terminal FGF23 measurements.
    Smith ER, Cai MM, McMahon LP, Holt SG.
    J Clin Endocrinol Metab; 2012 Sep 01; 97(9):3357-65. PubMed ID: 22689697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
    Sharma S, Katz R, Ginsberg C, Bullen A, Vallon V, Thomson S, Moe OW, Hoofnagle AN, de Leeuw PW, Kroon AA, Houben AJHM, Ix JH.
    J Bone Miner Res; 2022 Jun 01; 37(6):1170-1178. PubMed ID: 35373859
    [Abstract] [Full Text] [Related]

  • 16. Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.
    Roberts MA, Huang L, Lee D, MacGinley R, Troster SM, Kent AB, Bansal SS, Macdougall IC, McMahon LP.
    BMC Nephrol; 2016 Nov 16; 17(1):177. PubMed ID: 27852236
    [Abstract] [Full Text] [Related]

  • 17. Parenteral iron polymaltose changes i:c-terminal FGF23 ratios in iron deficiency, but not in dialysis patients.
    Tan SJ, Satake S, Smith ER, Toussaint ND, Hewitson TD, Holt SG.
    Eur J Clin Nutr; 2017 Feb 16; 71(2):180-184. PubMed ID: 27848940
    [Abstract] [Full Text] [Related]

  • 18. The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans.
    Bielesz B, Reiter T, Hammerle FP, Winnicki W, Bojic M, Gleiss A, Kieweg H, Ratzinger F, Sunder-Plassmann G, Marculescu R.
    J Clin Med; 2020 Aug 14; 9(8):. PubMed ID: 32823844
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
    Gkentzi D, Efthymiadou A, Kritikou D, Chrysis D.
    Bone; 2014 Sep 14; 66():8-14. PubMed ID: 24880094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.